Sign in

    Joe Federico • Stifel Financial Corp.

    Joe Federico is an Equity Analyst at Stifel, Nicolaus & Co., Inc., specializing in healthcare and medical device sector research. He has covered companies such as Cutera, focusing on operational and revenue drivers during quarterly earnings calls, and actively contributes research and analysis to institutional investor discussions. Federico began his career at Stifel, Nicolaus, where he currently holds a FINRA-registered representative status and maintains requisite securities licenses. While recognized for in-depth sector coverage, detailed analyst performance metrics and prior experience before Stifel are not publicly documented.

    Joe Federico's questions to Beauty Health Co (SKIN) leadership

    Joe Federico's questions to Beauty Health Co (SKIN) leadership • Q2 2025

    Question

    Joe Federico, on for Jon Block, asked for more detail on the EBITDA dynamics in the second-half guidance, specifically the step-down from the first half, and inquired about the specific drivers of the Q2 OpEx beat.

    Answer

    CFO Michael Monahan explained the second-half EBITDA step-down is a result of tariff headwinds, increased R&D spend, and gross margin pressure from a product mix skewed towards lower-priced refurbished units. He attributed the Q2 OpEx savings to disciplined ROI-focused spending in Sales & Marketing and lower G&A costs, which also benefited from bad debt recoveries. He projected S&M dollar spend to remain near Q2 levels for the rest of the year.

    Ask Fintool Equity Research AI